ESR1 and ductal breast carcinoma in situ: We obtained breast cancer tissue from a 44 year old premenopausal female with infiltrative ductal carcinoma (IDC) with ductal carcinoma in situ (DCIS), stage pT1c pN1, Grade II/III, estrogen receptor (ER) positive, progesterone receptor (PR) positive and Her2 negative.